The success of Moderna and Merck’s intismeran autogene doesn’t guarantee smooth sailing for other mRNA vaccine developers, ...

Nevertheless, in the past year, Merck (MRK) delivered an impressive 73% return to investors, outpacing the S&P 500. The peak ...

Check out some of the companies making the biggest moves midday: BJ's Wholesale — Shares gained 4% after the wholesale retailer posted better-than-expected results for the second quarter. BJ's earned ...

FOX Business anchors Lauren Simonetti and Stuart Varney track the latest market movers, highlighting Moderna's surge on cancer vaccine news and Coinbase's massive rally as Bitcoin climbs. The anchors ...

Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug ...

Moderna shares rise to close out a week of wild swings. Crypto stocks also extend their recent rally.

Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the ...

Ross Stores soars 9% on earnings beat while crypto stocks rally. Strategy posts $1.4B Bitcoin gain as BTC hits $78,500.

Cancer patients may be receiving higher doses and longer courses of expensive drugs than they need. Also, we see Moderna’s ...

The Food and Drug Administration granted accelerated approval to Zenbexus, or iberdomide, in combination with daratumumab and ...

Moderna and Merck's personalised cancer vaccine succeeds in a Phase 3 trial, raising hopes for a new generation of cancer ...

Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of ...